HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SPOK
Spok Holdings, Inc.
SPOK's fundamentals are mixed, but it looks cheap: trading at 13x earnings, below its usual 18x.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SPOK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
SPOK's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SPOK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.6x | $7.56 | -35% |
| Current | 13x | $11.62 | — |
| Fair | 18x | $15.91 | +37% |
| Expensive | 22x | $19.16 | +65% |
Historical ranges are pointers, not guarantees.
SPOK's PE is in its cheap range at 13x.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SPOK Forward outlook
There aren't enough analyst estimates for SPOK to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SPOK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.88 | +11% |
| Q2 2026 | $0.57 | -30% |
| Q1 2026 | $0.59 | -23% |
| Q4 2025 | $0.75 | +2.7% |
| Q3 2025 | $0.79 | +8.2% |
| Q2 2025 | $0.82 | +6.5% |
| Q1 2025 | $0.77 | -7.2% |
| Q4 2024 | $0.73 | -5.2% |
SPOK has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SPOK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
SPOK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $33M | -2.6% |
| Q2 2026 | $35M | -1.9% |
| Q1 2026 | $33.2M | -8.5% |
| Q4 2025 | $33.9M | -0.1% |
| Q3 2025 | $33.9M | -2.9% |
| Q2 2025 | $35.7M | +5% |
| Q1 2025 | $36.3M | +4% |
| Q4 2024 | $33.9M | -0.2% |
SPOK's revenue fell from its 2019 peak and has held roughly level since: $33M last quarter, down 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +4.2 points |
| Q2 2026 | 16% | +0.4 points |
| Q1 2026 | 7.4% | -9.2 points |
| Q4 2025 | 12% | -2 points |
| Q3 2025 | 13% | -1.4 points |
| Q2 2025 | 15% | +1.9 points |
| Q1 2025 | 17% | +2.6 points |
| Q4 2024 | 14% | +1.7 points |
SPOK has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SPOK on cash flow, with more consistent year-over-year improvement.
SPOK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.2M | +62% |
| Q2 2026 | $5.9M | -2% |
| Q1 2026 | $1.8M | +22% |
| Q4 2025 | $10.1M | +34% |
| Q3 2025 | $7.6M | -26% |
| Q2 2025 | $6M | -12% |
| Q1 2025 | $1.5M | +34% |
| Q4 2024 | $7.5M | -30% |
SPOK generated $30M in free cash flow over the past year, up 33% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SPOK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SPOK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +128K shares |
| 1 year | +0.9% | +184K shares |
| 3 years | +4.5% | +909K shares |
| 5 years | +9% | +1.7M shares |
| Available history | +11% | +2.1M shares |
SPOK has 21M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SPOK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
SPOK has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SPOK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.2 | Neutral |
| Stochastic | 76.0 | Neutral |
SPOK's weekly RSI is 55 (neutral) and its Stochastic is 76 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SPOK PE vs Healthcare Sector
| Metric | SPOK | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 49% below |
| PE % | 27 | 29 | 2 pts below |
SPOK is trading at 13x earnings, a 49% discount to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SPOK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 5.3% above |
| 20 week MA | $10.8 | 7.3% above |
| 50 week MA | $11.5 | 0.9% above |
| 100 week MA | $13.9 | 17% below |
| 200 week MA | $14.1 | 17% below |
SPOK has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SPOK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.1 | $11.0 | -9% |
| 2021 | $11.0 | $8.72 | -21% |
| 2022 | $8.72 | $8.24 | -5.5% |
| 2023 | $8.24 | $15.5 | +88% |
| 2024 | $15.5 | $16.2 | +4.8% |
| 2025 | $16.2 | $13.0 | -20% |
| 2026 YTD | $13.0 | $11.6 | -10% |
SPOK has the edge over HIMS on returns for 2026, with the stronger performance.